Last year the Radboud Biobank participated for the first time in the IBBL Biospecimen Proficiency Testing program endorsed by ISBER. This testing program is an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods and the efficiency of processing methods. The Radboud Biobank participated in the program for viable PBMC isolation and the program for cell free DNA Extraction from whole blood. Stabilized whole blood received from IBBL was processed by the Radboud Laboratory for Diagnostics by our standard procedure followed by the cfDNA extraction performed by the Genetics department. The PBMCs were isolated from donor blood by the Laboratory of Medical Immunology with the AutoMACS.
DNA and PBMCs where sent back to IBBL for the analysis. Recently we received the reports of the Proficiency tests which resulted in a quality certificate for both methods. The participants’ mean (n=11 cfDNA and n=53 PBMC) is considered as the assigned value and basic statistics were performed.
If you are interested in the methods or report in more detail, please contact the Radboud Biobank.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
One year since the new business model for the Radboud Biobank was implemented
3 March 2026The new business model was introduced last year, with departments paying half of the biomaterial processing costs, covering the storage costs, and applying a graduated rate for sample issuance.
go to page
Periodic invoicing biobank collections
3 March 2026Since 2025, the Radboud Biobank periodically charges all biobank collections for the processing and storage costs incurred.
go to page
The purpose of a central biobank facility such as the Radboud Biobank
3 March 2026As the central biobank facility of Radboudumc, the Radboud Biobank does more than simply store human biomaterials.
go to page
Radboud Biobank's 2025 annual report
3 March 2026The Radboud Biobank's 2025 annual report is now available on request.
go to page
Aevai Health developed a virtual assistant
3 March 2026Aevai Health has developed Alva - a virtual assistant to engage research participants, which can support participants with health literacy, understanding research protocols, and with using measurement devices.
go to page
Radboudumc Researchers Highlight Critical Gaps in Reporting Pre-Analytical Processes in Biobanked Biomaterials
21 October 2025Radboudumc Researchers have identified significant shortcomings in pre-analytical sample processing reporting in clinical biomarker research, a factor crucial for study reliability and replicability.
go to page